Review of the impact of molecular analysis on the therapy of medulloblastoma
Medulloblastoma (MB) is a brain tumor composed of distinct molecularly defined subgroups. Recent advances in genomics and transcriptomics have revealed >12 subtypes within the previously identified four subgroups. Molecular classification has improved clinical outcome predictions and facilitated...
Main Authors: | Supriya Sarvode, Amar Gajjar |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-06-01
|
Series: | Pediatric Hematology Oncology Journal |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2468124523000268 |
Similar Items
-
Research progress in molecular pathology markers in medulloblastoma
by: Zixuan Zhou, et al.
Published: (2023-02-01) -
Is adult medulloblastoma merely the counterpart of pediatric medulloblastoma?
by: Gabriel Chun-Hei Wong, et al.
Published: (2020-01-01) -
Medulloblastoma: clinicopathological parameters, risk stratification, and survival analysis of immunohistochemically validated molecular subgroups
by: Asmaa Mustafa Eid, et al.
Published: (2021-02-01) -
Successful Implementation of Image-Guided Pencil-Beam Scanning Proton Therapy in Medulloblastomas
by: Anindita Das, et al.
Published: (2023-11-01) -
Identification of CD114 Membrane Receptors as a Molecular Target in Medulloblastomas
by: Jander Moreira Monteiro, et al.
Published: (2023-03-01)